Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.

Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, Poynor EA, Aghajanian C, Spriggs D, Hensley ML, Sabbatini P.

Gynecol Oncol. 2007 Jan;104(1):176-80. Epub 2006 Sep 25.

PMID:
16996584
2.

Advances in the management of epithelial ovarian cancer.

Berkenblit A, Cannistra SA.

J Reprod Med. 2005 Jun;50(6):426-38. Review.

PMID:
16050567
3.

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH.

Gynecol Oncol. 2003 Dec;91(3):463-9. Review.

PMID:
14675663
4.

Second-look laparotomy in carcinoma of the fallopian tube.

Barakat RR, Rubin SC, Saigo PE, Lewis JL Jr, Jones WB, Curtin JP.

Obstet Gynecol. 1993 Nov;82(5):748-51. Review.

PMID:
8414320
5.

Carcinosarcoma of the ovary: analysis of 13 cases and review of the literature.

Loizzi V, Cormio G, Camporeale A, Falagario M, De Mitri P, Scardigno D, Putignano G, Selvaggi LE.

Oncology. 2011;80(1-2):102-6. doi: 10.1159/000328794. Epub 2011 Jun 14. Review.

PMID:
21677454
6.

[Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].

Pautier P, Rey A, Michel G, Castaigne D, Rochard F, Duvillard P, Haie-Meder C, Curcio P, Benedetti-Richard L, Lhommé C.

Bull Cancer. 1997 Feb;84(2):147-54. Review. French.

7.

Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy.

Lu MJ, Sorich J, Hazarika M, Kim M, Del Priore G, Jacobs AJ, Chiang C, Liu PC, Fusco E, Curtin JP, Muggia FM.

Hematol Oncol Clin North Am. 2003 Aug;17(4):969-75. Review.

PMID:
12959186
8.

Ovarian cancer metastatic to the brain: what is the optimal management?

McMeekin DS, Kamelle SA, Vasilev SA, Tillmanns TD, Gould NS, Scribner DR, Gold MA, Guruswamy S, Mannel RS.

J Surg Oncol. 2001 Nov;78(3):194-200; discussion 200-1. Review.

PMID:
11745806
9.

[Treatment of ovarian cancer].

Cianti C.

Clin Ter. 2002 Mar-Apr;153(2):135-44. Review. Italian.

PMID:
12078339
10.

New tumor markers: CA125 and beyond.

Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K.

Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81. Review.

PMID:
16343244
11.

Treatment goals in ovarian cancer.

Ozols RF.

Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:3-11. Review.

PMID:
15839952
12.

Role of chemotherapy in the management of epithelial ovarian cancer.

Reed NS, Sadozye AH.

Expert Rev Anticancer Ther. 2005 Feb;5(1):139-47. Review.

PMID:
15757446
13.

Rationale for maintenance or consolidation therapy in ovarian cancer.

Markman M.

Clin Adv Hematol Oncol. 2003 Mar;1(3):176-8. Review.

PMID:
16224399
14.

Intraperitoneal chemotherapy in ovarian cancer: who and when?

Tournigand C.

Curr Opin Obstet Gynecol. 2005 Feb;17(1):83-6. Review.

PMID:
15711417
15.

Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survival.

Wilkerson J, Fojo T.

Cancer J. 2009 Sep-Oct;15(5):379-85. doi: 10.1097/PPO.0b013e3181bef8cd. Review.

PMID:
19826357
16.

Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.

Saad ED, Katz A, Buyse M.

J Clin Oncol. 2010 Apr 10;28(11):1958-62. doi: 10.1200/JCO.2009.25.5414. Epub 2010 Mar 1. Review.

PMID:
20194852
17.

[Therapeutic options for patients with localized prostatic carcinoma: our experience with 454 patients].

Arrizabalaga Moreno M, García González JI, Pérez Garnelo MJ, Paniagua Andrés P.

Actas Urol Esp. 2004 Jun;28(6):418-31. Review. Spanish.

PMID:
15341391
18.
19.

Management of recurrent ovarian cancer: evidence-based decisions.

Salom E, Almeida Z, Mirhashemi R.

Curr Opin Oncol. 2002 Sep;14(5):519-27. Review.

PMID:
12192271
20.

Contemporary management of ovarian cancer.

Im DD, McGuire WP, Rosenshein NB.

Obstet Gynecol Clin North Am. 2001 Dec;28(4):759-73. Review.

PMID:
11766150

Supplemental Content

Support Center